Charming Medical Ltd

MCTA Nasdaq SEC CIK 2035992
Follow Charming Medical Weekly email: filings, results

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income3 fiscal years
  • Revenue
  • Net income
−$2M$0$2M$4M$6M$8MFY24FY25FY26
Show the numbers
YearRevenueNet income
FY26$4.8M−$22.6K
FY25$6.2M$1.2M
FY24$6M$777.8K
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−50%0%50%100%FY24FY25FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2699.3%−0.6%−0.5%
FY2599.8%22.3%19.3%
FY2499.8%16.8%12.9%
Free cash flowOperating cash flow minus capital expenditure
−$2M−$1.5M−$1M−$500K$0$500KFY24FY25FY26
Show the numbers
YearFree cash flow
FY26−$1.6M
FY25$138.4K
FY24$84.8K
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Charming Medical
  • Healthcare median
−60%−40%−20%0%20%FY24FY25FY26
Show the numbers
YearCharming MedicalHealthcare median
FY26−0.5%−11.1%
FY2519.3%−30.6%
FY2412.9%−47%